# Open-Label Placebo for Functional Dyspepsia

> **NCT03745781** · EARLY_PHASE1 · TERMINATED · sponsor: **Beth Israel Deaconess Medical Center** · enrollment: 21 (actual)

## Conditions studied

- Dyspepsia

## Interventions

- **DRUG:** Placebos

## Key facts

- **NCT ID:** NCT03745781
- **Lead sponsor:** Beth Israel Deaconess Medical Center
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-12-01
- **Primary completion:** 2019-10-07
- **Final completion:** 2019-10-07
- **Target enrollment:** 21 (ACTUAL)
- **Why stopped:** low enrollment
- **Last updated:** 2020-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03745781

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03745781, "Open-Label Placebo for Functional Dyspepsia". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03745781. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*